Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas

Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas

Patients with liver-dominant metastatic or primary hepatic soft tissue sarcomas (STS) have poor prognosis. Surgery can prolong survival, but most patients are not surgical candidates, and treatment response is limited with systemic chemotherapy. Liver-directed therapies have been increasingly employ...

Full description

Bibliographic Details
Main Authors: Stefano Testa, Nam Q. Bui, David S. Wang, John D. Louie, Daniel Y. Sze, Kristen N. Ganjoo
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
trans-arterial radioembolization
soft-tissue sarcomas
Yttrium-90
liver
Online Access:https://www.mdpi.com/2072-6694/14/2/324

Internet

https://www.mdpi.com/2072-6694/14/2/324

Similar Items